Benfey B G
Department of Pharmacology and Therapeutics, McGill University, Montréal, Que., Canada.
Can J Physiol Pharmacol. 1993 Feb;71(2):103-11. doi: 10.1139/y93-015.
The myocardium of animals and man possesses alpha 1-adrenoceptors in addition to beta-adrenoceptors. Ischemia increases sympathetic tone, and ventricular arrhythmias can occur by beta- and alpha 1-adrenoceptor stimulation. I believe that alpha 1-adrenoceptor blocking drugs have antifibrillatory effects and will review the data that support this condition. The effect of alpha 1-adrenoceptor blocking drugs on the incidence of ventricular fibrillation in acute coronary artery occlusion and (or) reperfusion has been determined in 24 studies in conscious and anesthetized dogs and rats, anesthetized cats and pigs, and rat and guinea-pig isolated hearts. The drugs reduced the incidence of fibrillation from 35 to 24% in coronary occlusion and from 61 to 29% in reperfusion.
除了β-肾上腺素能受体外,动物和人类的心肌还具有α1-肾上腺素能受体。缺血会增加交感神经张力,通过β-肾上腺素能受体和α1-肾上腺素能受体刺激可发生室性心律失常。我认为α1-肾上腺素能受体阻断药物具有抗纤颤作用,并将回顾支持这一观点的数据。在清醒和麻醉的犬、大鼠、麻醉的猫和猪以及大鼠和豚鼠离体心脏的24项研究中,已确定了α1-肾上腺素能受体阻断药物对急性冠状动脉闭塞和(或)再灌注时室颤发生率的影响。这些药物使冠状动脉闭塞时的纤颤发生率从35%降至24%,再灌注时从61%降至29%。